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Summary A Genesis stent was implanted in two children, one with superior vena
caval (SVC) stenosis and one with pulmonary artery branch stenosis. Case 1 was a 2-
month-old baby with SVC stenosis following intracardiac repair for total anomalous
pulmonary venous connection (TAPVC) and case 2 was a 2-year-old child with left
lower pulmonary artery stenosis following one-stage unifocalization for dextrocar-
dia, double outlet right ventricle, ventricular septal defect, pulmonary atresia and
major aortopulmonary collateral arteries. Both procedures resulted in immediate
clinical and hemodynamic improvement. The Genesis stent has a closed-cell design
with sigma hinges interpositioned between each cell. With improved deliverability
and expandability of the stent, we can easily deliver it through smaller sheaths,
use
ge of
swhich will facilitate its
© 2008 Japanese Colle
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Case reportThe Genesis stent (Cordis, Warren, NJ, USA), which
was initially developed for the treatment of biliary
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tenosis, is very ﬂexible, can traverse tortuous ves-
els, and has good radial strength with a lower pro-
le delivery system [1,2]. There are some reports
f the advantageous properties of the Genesis stent
nd its potential use in infants and small chil-
ren with congenital heart disease. We attempted
mplantation of the Genesis stent without using a
ong sheath in a 2400 g baby with superior vena
gy. Published by Elsevier Ireland Ltd. All rights reserved.
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nenesis stent implantation
aval (SVC) syndrome complicating repair of total
nomalous pulmonary venous connection, and in a
-year-old child with left pulmonary artery stenosis
fter percutaneous transluminal angioplasty (PTA)
omplicated by intimal dissection.
Written informed consent for stent implantation
nd off-label use of the Genesis stent was obtained
rom the parents of both patients. The ethical com-
ittee of our hospital also approved its use.
ase 1
2-month-old baby weighing 2400 g developed SVC
yndrome 40 days after intracardiac repair of total
nomalous pulmonary venous connection (TAPVC)
t 5 days of age. Angiography 50 days after surgery
emonstrated a tight stenosis of the SVC with a
ressure gradient of 11mmHg (Fig. 1) and mild
eft pulmonary venous obstruction. The SVC syn-
rome was progressive and was complicated by
ersistent chylothorax, unresponsive to 2 weeks of
ntensive medical treatment, while the pulmonary
enous obstruction was tolerated. Therefore, we
lanned stent implantation for the SVC stenosis
4 days after surgery. The procedure was per-
igure 1 A superior vena cavogram showing stenosis
ear the SVC—RA junction.
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tigure 2 A superior vena cavogram showing excellent
ow through the SVC after deployment of the stent.
ormed under general anesthesia with orotracheal
ntubation. A 5F sheath was placed in the right
emoral vein and 100U/kg of heparin was admin-
stered. Without using a long sheath, a Genesis
tent on a Slalom with a diameter of 5mm and a
ength of 15mm (PG1550BSS) was advanced into
he SVC and was deployed in the area of steno-
is near the SVC right atrium (RA) junction which
as conﬁrmed by a test angiogram from the left
rm. The post-stent angiogram revealed excellent
ow through the SVC with no evidence of nar-
owing (Fig. 2). There was no pressure gradient
cross the stenosis. He was heparinized overnight
ith an intravenous infusion of 200U/(kg day). The
ost-produce antithrombotic regimen consisted
f oral dipyridamole 3mg/(kg day) and warfarin
.02mg/(kg day). Although he died of pulmonary
enous occlusion 1 month after stent implantation,
here was no recurrence of the SVC obstruction.
ase 22-year-old child with 47XYY karyotype, dextro-
ardia, double outlet right ventricle, ventricular
eptal defect, pulmonary atresia, and major aor-
opulmonary collateral arteries underwent midline
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one-stage complete unifocalization at 4 months of
age and intracardiac repair at 1 year of age. His
body weight was 10.8 kg and height was 86.7 cm. He
had PTA for left lower pulmonary artery stenosis at
13 months of age, which was complicated by inti-
mal ﬂap formation. Stenosis persisted around the
previous intimal ﬂap. Re-PTA at 1 year 8 months
of age was ineffective. A pulmonary perfusion scan
revealed severe hypoperfusion of the left lower
lung. At cardiac catheterization under general
anesthesia with orotracheal intubation, the main,
left and right pulmonary artery pressure were 38/6
(mean, 20), 38/6 (20), and 26/6 (15) mmHg, respec-
tively. A left pulmonary angiogram demonstrated
stenosis of the left lower pulmonary artery (Fig. 3).
We decided to implant a Genesis stent to rescue
it. A 6F sheath was placed in the right femoral
vein and 100U/kg of heparin was administered. A
6F long sheath (Brite tip, Cordis) was positioned in
the main pulmonary artery. After predilation using
a SASUGA (Boston Scientiﬁc, Natick, MA, USA), with
a balloon diameter of 5mm and a length of 2mm,
the Genesis stent on a Slalom with a diameter
of 5mm and a length of 15mm (PG1550BSS) was
deployed in the lesion. Although we introduced the
long sheath in the main pulmonary artery, it was
not advanced through the lesion because of tortu-
Figure 3 A left lower pulmonary angiogram showing
stenosis around the intimal ﬂap.
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oigure 4 A left lower pulmonary angiogram showing
xcellent ﬂow through the lesion after deployment of the
tent.
us and stenotic blood vessels. Consequently, the
tent was advanced to the lesion from the long
heath in the main pulmonary artery. The post-
tent angiogram revealed excellent ﬂow through
he lesion (Fig. 4). He was heparinized overnight
ith an intravenous infusion of 200U/(kg day). The
ost-procedure antithrombotic regimen consisted
f oral ticlopidine HCl 5mg/(kg day) and aspirin
mg/(kg day).
iscussion
n Japan, intravascular stenting has been increas-
ngly used for various congenital and postoperative
ascular stenoses even in children. Although various
ew generation stents have been released in North
merica and Europe, the only stent approved for
se in large vessels in Japan is the original Palmaz.
t has several limitations when used in infants and
mall children, including a rigid strut, a sharp edge,
nd the need for a relatively large sheath to deploy
t [2]. Even a medium sized original Palmaz stent
eeds a 7F sheath to deploy, while the larger Palmaz
equires an 8F or larger sheath depending on the
ize of the balloon on which the stent is mounted.
There are a few reports on stenting for SVC
bstruction in infants [3]. Frias et al. [4] reported
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[enesis stent implantation
he successful implantation of a P188 stent in a
.5 kg infant with SVC stenosis using an 8F long
heath. Case 1 in the present study required relief
f the SVC obstruction to avoid cerebral hemor-
hage, infection, and hypo-nutrition following the
ersistent drainage of chyle from the right pleural
avity and high venous pressure despite intensive
edical management. Although balloon dilation is
ne management option, immediate restenosis can
ccur due to elastic recoil after the procedure
5]. Considering it, we decided to implant a stent.
lthough the medium sized Genesis stent, which
an go through a 5F sheath unlike a medium or large
riginal Palmaz, has limited re-dilatation potential
ompared to the original large Palmaz, because of
he low weight of our baby, we chose the Genesis
tent.
In case 2, stenting of pulmonary artery branch
tenosis may contribute to reducing pulmonary
egurgitation and preserving as much pulmonary
asculature as possible [6]. Considering the small
rea supplied by the left lower pulmonary artery,
e chose to implant a medium sized Genesis stent.
e placed a 6F long sheath in the main pulmonary
rtery, because it was difﬁcult to deliver it through
he left lower pulmonary artery. However, the Gen-
sis stent could be easily delivered to the left lower
esion without the use of a long sheath. A long
heath is sometimes difﬁcult to position, and its
pplication may be associated with vascular com-
lications or hemodynamic compromise, especially
n infants and small children [7]. Our experience
uggests that the Genesis stent can be implanted in
VC and pulmonary branch stenosis without using a
ong sheath even in infants and small children with
[
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ongenital heart disease. Early introduction of the
enesis Extra Diameter series, which has a poten-
ial maximal diameter of 18mm, and is available
n lengths from 19 to 59mm, is warranted in our
ountry.
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